Article and Video CATEGORIES

Cancer Journey

Search By

Dr. Jack West is a medical oncologist and thoracic oncology specialist who is the Founder and previously served as President & CEO, currently a member of the Board of Directors of the Global Resource for Advancing Cancer Education (GRACE)

 

ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC by Dr. Edward Garon
Author
Howard (Jack) West, MD

Responses in the CNSDr. Edward Garon, David Geffen School of Medicine at UCLA, describes the exciting developments with LDK-378 and potentially other second generation ALK inhibitors for crizotinib-resistant ALK-positive advanced NSCLC.

 

[powerpress]

ASCO Lung Cancer Highlights, Part 10: Strategies After Resistance to Crizotinib in ALK-Positive Advanced NSCLC Audio Podcast

Next Previous link

Previous PostNext Post

Related Content

Online Community

Hi James Anthony, I'm so sorry you are going through this and so very young.  It' s true that some people benefit for years with chemo and targeted therapies.  With the...

Hi siigs, I'm sorry you're having health issues. They don't sound like pancoast tumor symptoms.  A consult with a pulmonologist can help to understand your chest symptoms and work toward alleviating...

Hi Lonnie, 

Yes, the info in last year's OncTalk was up to date at that moment.  I think it would be well worth the watch along with videos in our 2025...

Hello Natalieaster, Welcome to Grace.  I hope your stay with us is short, but we are always here to answer, listen and share.  

Since your doctor didn't seem too worried...

Recent Comments

JOIN THE CONVERSATION
ROS 1
By JanineT GRACE … on
Hi siigs, I'm sorry you're…
By JanineT GRACE … on
Tomorrow Saturday, Oct. 25, 2025
By JanineT GRACE … on
Blood Cancers OncTalk-Live, Free, Learn Sat. Oct. 25
By JanineT GRACE … on